Meta-Analysis: No Benefit For Cardiac Resynch In Patients With Narrow QRS Interval
This article was originally published in The Gray Sheet
Executive Summary
Cardiac resynchronization therapy may not benefit up to 40% of heart failure patients who currently receive CRT devices and whose “QRS duration” on an electrocardiogram is below a certain threshold, according to a meta-analysis published June 13.